Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hao, Xu ^a   Liu, Xia ^b   Wang, Weiming ^a   Ren, Hong ^a   Xie, Jingyuan ^a   Shen, Pingyan ^a   Lin, Donghai ^b,c   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLNICOTINAMIDE; 3 METHYLHISTIDINE; CITRIC ACID; DIMETHYLAMINE; GLUCOSE; GLYCINE; HIPPURIC ACID; ISOLEUCINE; ISOVALERIC ACID; PHENYLACETYLGLYCINE; PYRUVIC ACID; TRIMETHYLAMINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; METABOLOMICS; MINIMAL CHANGE GLOMERULONEPHRITIS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE; PATHOGENESIS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 84892921460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078531     Document Type: Article

References (42)

1. Gbadegesin R, Lavin P, Foreman J, Winn M (2011) Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol 26: 1001-1015.
2. Cameron JS (2003) Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 18 Suppl 6: vi45-51.
3. Rich AR (1957) A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100: 173-186.
4. Kriz W (2003) The pathogenesis of 'classic' focal segmental glomerulosclerosis-lessons from rat models. Nephrol Dial Transplant 18 Suppl 6: vi39-44.
5. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, et al. (2009) Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20: 1041-1052.
6. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, et al. (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952. (Pubitemid 44743492)
7. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
8. Mao H, Wang H, Wang B, Liu X, Gao H, et al. (2009) Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. J Proteome Res 8: 5423-5430.
9. Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, et al. (2010) Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res 9: 2988-2995.
10. McDunn JE, Li Z, Adam KP, Neri BP, Wolfert RL, et al. (2013) Metabolomic signatures of aggressive prostate cancer. Prostate 73: 1547-1560.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. (Pubitemid 29135798)
12. Dieterle F, Ross A, Schlotterbeck G, Senn H (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 78: 4281-4290.
13. Nicholson JK, Wilson ID (2003) Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676. (Pubitemid 37361770)
14. Mannon RB (2010) Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney Int Suppl. S59-65.
15. Beger RD, Holland RD, Sun J, Schnackenberg LK, Moore PC, et al. (2008) Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol 23: 977-984.
16. Zira AN, Theocharis SE, Mitropoulos D, Migdalis V, Mikros E (2010) (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. J Proteome Res 9: 4038-4044.
17. Zhang J, Yan L, Chen W, Lin L, Song X, et al. (2009) Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOFMS system. Anal Chim Acta 650: 16-22.
18. Trygg J BM, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, et al. (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemometr 20: 341-351.
19. Li M, Song Y, Cho N, Chang JM, Koo HR, et al. (2011) An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy. PLoS One 6: e25563.
20. Carrola J, Rocha CM, Barros AS, Gil AM, Goodfellow BJ, et al. (2011) Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10: 221-230.
21. Klawitter J, Bendrick-Peart J, Rudolph B, Beckey V, Klawitter J, et al. (2009) Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function. Chem Res Toxicol 22: 118-128.
22. Postma PW, Cools A, van Dam K (1973) The transport of Krebs-cycle intermediates in Azotobacter vinelandii under various metabolic conditions. Biochim Biophys Acta 318: 91-104.
23. Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95-158.
24. Mandel LJ (1985) Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport. Annu Rev Physiol 47: 85-101.
25. Yu PH (1998) Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Transm Suppl 52: 201-216.
26. Beltowski J, Kedra A (2006) Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol Rep 58: 159-178.
27. Sydow K, Munzel T (2003) ADMA and oxidative stress. Atheroscler Suppl 4: 41-51. (Pubitemid 38234494)
28. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, et al. (2007) Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 18: 799-810. (Pubitemid 46434497)
29. Poon K, Pang KS (1995) Benzoic acid glycine conjugation in the isolated perfused rat kidney. Drug Metab Dispos 23: 255-260.
30. Chiba M, Poon K, Hollands J, Pang KS (1994) Glycine conjugation activity of benzoic acid and its acinar localization in the perfused rat liver. J Pharmacol Exp Ther 268: 409-416. (Pubitemid 24039116)
31. Strahl NR, Barr WH (1971) Intestinal drug absorption and metabolism. 3. Glycine conjugation and accumulation of benzoic acid in rat intestinal tissue. J Pharm Sci 60: 278-281.
32. Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, et al. (2002) Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther 303: 880-887. (Pubitemid 35231266)
33. Deguchi T, Takemoto M, Uehara N, Lindup WE, Suenaga A, et al. (2005) Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J Pharmacol Exp Ther 314: 932-938. (Pubitemid 41043880)
34. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, et al. (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943. (Pubitemid 36513344)
35. Huszar G, Golenwsky G, Maiocco J, Davis E (1983) Urinary 3-methylhistidine excretion in man: the role of protein-bound and soluble 3-methylhistidine. Br J Nutr 49: 287-294. (Pubitemid 13028048)
36. Long CL, Haverberg LN, Young VR, Kinney JM, Munro HN, et al. (1975) Metabolism of 3-methylhistidine in man. Metabolism 24: 929-935.
37. Cross AJ, Major JM, Sinha R (2011) Urinary biomarkers of meat consumption. Cancer Epidemiol Biomarkers Prev 20: 1107-1111.
38. Wang H, Hu P, Jiang J (2012) Measurement of 1- and 3-methylhistidine in human urine by ultra performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 413: 131-138.
39. Lin L, Yu Q, Yan X, Hang W, Zheng J, et al. (2010) Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst 135: 2970-2978.
40. Chattopadhyay D, Ghosh NC, Chattopadhyay H, Banerjee S (1953) Studies on the metabolism of nicotinic acid in rabbits. J Biol Chem 201: 529-534.
41. Maiza A, Waldek S, Ballardie FW, Daley-Yates PT (1992) Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide. Nephron 60: 12-16.
42. Burckhardt G, Wolff NA (2000) Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 278: F853-866. (Pubitemid 30441351)